SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bio " 2,870 found 🔀 AI-powered Shuffle
FSU's ICON-Health marks first anniversary, announces new biomarker research facility
Florida State University’s Institute for Connecting Nutrition and Health (ICON-Health) marked its first anniversary by announcing plans for a new
FSU's ICON-Health marks first anniversary, announces new biomarker research facility
Florida State University’s Institute for Connecting Nutrition and Health (ICON-Health) marked its first anniversary by announcing plans for a new
Vanderbilt mourns loss of laboratory legend Howard Price
Howard Price, a technical supervisor in the Department of Pathology, Microbiology and Immunology, and with 67 years of employment, the longest serving member of the Vanderbilt Health family, died Oct. 12. He was 85.
When computer science meets the alpaca immune system
After earning bachelor's and Ph.D. degrees in bioengineering with a focus on molecular biology, Will White, a postdoctoral scholar in the Department of Computer Science at Tufts, was pretty certain his ...
Treat Pandemic Preparedness As Strategic ‘Biodefence’, Industry And Health Leaders Urge
Speaking at a flagship World Health Summit panel global health officials and pharmaceutical executives urged governments to reframe pandemic preparedness as ‘biodefence’ - a core national security asset and not a discretionary health expenditure.
Battlefield 6 Quietly Yanks Planned Mass Effect Collab From Its Store After BioWare Closure
The EA-owned military shooter has collaborated with the sci-fi RPG in bad taste before
Pope hope, that’s entertainment, and getting ahead in the CIA
Happy Friday friends, I want to start by just breathing for all of us a big long collective sigh of relief at the news this week that the pope’s doctors have basically blown the all clear for Leo’s health. Going from knowing nothing to him declaring to the world he needed surgery, to a cancer diagnosis, to bouncing out of the hospital in barely even days, to ringing the bell in less than two weeks is whiplash inducing. But in the best possible way. We are living in a world in which the Roman pontiff, by dint of history, biography and circumstance, is once more at the epicenter of global affairs. Not just conversations about religion, or Christian and post-Christian values, but the bleeding edge of the most pressing issues of human affairs. Think I am exaggerating a touch? Consider the images of the crowds who greeted Leo in Paris just weeks ago, and juxtapose them with the absolute photo negative scenes unfolding there recently. Ask yourself how many world leaders are talking about AI right now and directly citing the pope as they do so. Try to name a country who has had as many top-ranked diplomats in and out of both Russia and Ukraine in the last three years as the Vatican has in the last three months. It has been fascinating to watch Leo XIV emerge as not just a kind of pop culture reference point or totem to be cited (Francis was often name-checked this way) but as a kinetic force in global conversation. Given the state of things, we need global figures of gravitas and values, even better if they have real wisdom behind what they are saying. So news of Leo’s illness was, it seemed to me, a tremor with potentially Richter Scale implications. That not only has the worst not come to pass but instead we’ve had the best of outcomes announced is something to really be grateful for. Humanity, it seems to me, is entering one of its irregular but cyclical phases where the pace of change — technological, social, and geopolitical — outstrips the ability of previously settled norms and received wisdom to cope. Such periods – and I think the first decades of the last century were a similar such time – throw into question the viability of all kinds of institutions. And many of ours have been straining to breaking point for a few years now. The papacy has the power and the potential to be a steadying pole in all of this. That’s my hope, anyway. It’s a lot to freight the office with, though it is arguably its ultimate purpose from its founding, to be a steadying rock on which all that matters can be anchored. It’s also, of course, an intolerable weight of responsibility to place on a single man. But I am encouraged to have hope in – and for – Leo. The apostle whom he succeeds, after all, was famously unequal to some moments, failed some tests of faith, and resiled from taking the road which led ultimately to the circus on Vatican hill. Human frailty and limitations, of health, of character, of temper, can open us to Christ, whose strength is greatest in our weakness, so St. Paul learned. That gives me hope, and I am sure it consoles Leo, too. And so I will continue to pray for him. Because we need apostles of rock right now. Here’s the news. Subscribe The News The Dicastery for the Doctrine of the Faith issued yesterday a new document “Venite ad me: Considerations on the Transmission of the Faith in an Epochal Change.” It’s not a short document, and it is at pains to stress this isn’t a doctrinal note from the dicastery, either. Rather, it brings together reflections on an important issue from the Church around the world. Some of it I actually found really rather powerful. It is, however, 25,000, which is a lot for a busy reader to get through on a weekday. So, you can read our busy reader’s summary right here. — News broke yesterday of an Oct. 22 meeting of U.S. bishops with President Donald Trump. The meeting was organized by an official at the Heritage Foundation, according to several sources close to the meeting. Video of several U.S. bishops praying in the Oval Office over President Trump was posted on social media Thursday afternoon, first by White House Communications Advisor Margo Martin, and then by the official twitter.com account of the Archdiocese of Denver. The meeting has drawn sharp criticism because of its proximity to the upcoming midterm Congressional elections, in which Democrats are widely expected to win control of the House of Representatives, while control of the Senate remains closely contested. Sources close to the bishops’ conference told The Pillar that some USCCB senior officials were surprised by the existence of the meeting when video of it first emerged online. And a source close to conference president Archbishop Paul Coakley of Oklahoma City told The Pillar that the archbishop was “deeply frustrated” by the occasion of the meeting. An official conference spokesperson told The Pillar that the meeting was “not organized with or by the USCCB” and was “not affiliated with the conference.” You can read the whole story here. — The next National Eucharistic Congress will be held in Indianapolis in 2029, a return to the city that hosted the last gathering in 2024. You read it here first. By here, I don’t mean this newsletter, I mean at The Pillar. We broke the story this week. It’s a big deal, in as much as the last congress was a roaring success and the next installment has the potential to be a real focal point for evangelizing efforts in the coming years. Read all about it here. — As Pope Leo prepares for the longest trip of his pontificate, Church leaders in Uruguay say the pontiff will encounter a highly secularized culture, in a country with a very different Catholic history than many of its South American neighbors. The nation has not had a papal visit since 1988, and leaders who spoke with The Pillar say it has a dire need for evangelization, even amid the prospect of a small revival in faith. This is real reporting on the Church in the country, and frankly a story you simply are not going to be able to read anywhere else. Read the whole thing. — The Archdiocese of Detroit announced this week a plan that would see the vast majority of its parish priests reassigned next summer, amid a restructuring process expected to dramatically shrink the number of parishes in the archdiocese. Archbishop Edward Weisenburger said this week that the plan “asks much of our priests,” but is a “sacrifice they are making as brothers of one, unified presbyterate.” The thing is, as JD pointed out in an analysis yesterday, pastors of parishes have a legal right to stability in office, so the only way this kind of wholesale reassignment goes ahead is if all of the archdiocesan clergy agree to resign. That creates its own kind of legal issues, though, and re-raises longstanding questions about the effectiveness of canonical due process protections for priests when dealing with coercive exercises in authority. Read the whole thing here. — More than three months after the Dicastery for the Doctrine of the Faith issued its decree declaring the excommunication of the leadership of the Society of St. Pius X, questions remain about the full effects of the society’s schism. Specifically, the DDF’s July claim that marriages witnessed and confessions heard by SSPX priests are now invalid remains contested — and it emerged this week it appears that the Vatican’s own legal experts don’t agree. You can read my whole analysis of the situation and what it means here. All I would add is that the DDF’s undeveloped, some would say unsubstantiated, claim about the invalidity of some SSPX sacraments came in their July Explanatory Note on the schismatic consecrations by the society that month. It touches directly on both papal acts of governance — indeed it purports to nullify them — and the most intimate pastoral encounters possible in a parish setting. If there is one aspect of the Francis-era style of governance I would like the curia to finally cut out, root and branch, it would be these attempts to try to effect extraordinarily sensitive legislative acts via a note. — At least a dozen French bishops have spoken out following an eruption of violence on the country’s streets Oct. 17. Not surprisingly, they unanimously condemned the violence, but the length and content of their interventions varied significantly. Several sought to distinguish between the actions of rioters and what they suggested were the legitimate concerns of peaceful young protesters. Many also evoked Pope Leo XIV’s Sept. 25-28 visit to France, suggesting it offered a powerful counter-image to the scenes of looting and destruction. A number of bishops also stressed their solidarity with law enforcement officials who struggled to contain the disorder, as well as the owners of the roughly 3,000 damaged or looted businesses. What’s the background to the nationwide unrest that the French media calls “les violences du 17 octobre”? And what exactly are the bishops saying? Read all about it here. — A Polish bishop called for the firm defense of unborn children as well as compassion for their mothers this week, as the lower house of Poland’s parliament passed two bills seeking to liberalize the country’s abortion laws. The bill on decriminalizing assistance in an abortion passed by 217 votes to 213, while the abortion in cases of fetal abnormality bill passed by 233 to 203, thanks to the government’s majority in the lower house. Both bills will now move to the Polish Senate, the upper house of parliament, where the ruling coalition has a larger majority. The fetal abnormality bill is symbolically significant because if it became law, it would effectively overturn a 2020 ruling by Poland’s Constitutional Tribunal that a 1993 law permitting abortion for a severe and irreversible disability or a life-threatening incurable disease was unconstitutional. Read the whole story here. Subscribe **[The St. Paul Center App | Bible Study On-The-Go Read and understand the Bible with St. Paul Center’s new app! With today’s leading Catholic Scripture scholars as your guides, the St. Paul Center app empowers you to read the Bible](https://stpaulcenter.com/app?utm_source=pillar&utm_medium=email&utm_campaign=applaunch)** from the heart of the Church. Download the app for free at either the Apple or the Google app stores. https://stpaulcenter.com/app That’s entertainment I have written before about my deep and sincere reservations about the celebrity exorcist subculture which has taken root in American Catholicism. And, because I am very ill at ease with the entire thing, I try to keep a weather eye on the phenomenon without being drawn into the kind of online back-and-forth which these figures sometimes generate. Earlier this week, JD noted that one such celebrity exorcist type, Fr. Chad Ripperger, has undertaken, on the request of his bishop, a year’s fast from interviews and public speaking. I’m sure that will be salutary for him, if for no other reason than that receiving with docility requests from one’s rightful ecclesiastical superiors always comes with graces. Then a second thing happened this week which caught my eye. Apparently, another fixture in the celebrity exorcist world, Fr. Carlos Martins, has initiated a lawsuit against two lay men — apparently associates of Rippenger, though I am unclear in what way, exactly — for allegedly defaming him and his ministry on a podcast. It seems the suit was initiated nearly a year ago and is now pending. At issue, I read, is that the two men described Martins on a podcast as “not who he says he is” with regard to his exorcism ministry and that he “doesn’t know what he’s talking about.” These statements Martins considers to be false and defamatory and, his suit claims, “directly affected the sale and reception of [his] The Exorcist Files book that was newly released at the time these episodes aired.” I don’t want to get too into the weeds of the details here, but a couple of things struck me about all this.
BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the life sciences
BioUK, the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced the winners of the 18 th annual BioUK Awards following a ceremony hosted at the...
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and
Scientists can now 'watermark' AI-generated proteins to deter bioweapon creation. But will it really work?
A new technology encodes an invisible mark into the structure of AI-generated proteins, but experts said the system's guardrails can still be bypassed.
Dental implants can hijack your immune system, scientists discover
Researchers have uncovered a surprising reason dental implant infections often resist antibiotics: the implants themselves can contribute to the problem. Bacteria corrode titanium implants, releasing microscopic particles that hijack immune cells, trigger destructive inflammation, and accelerate jawbone loss.
Changing shape of healthcare careers: Medical AI, Bioinformatics and Health Data Science
Changing shape of healthcare careers: Medical AI, Bioinformatics and Health Data Science
Withings and Function Integrate Connected Health Data with Comprehensive Lab Testing
Withings and Function have announced a partnership integrating connected health device measurements with comprehensive laboratory testing, enabling users to access daily biometric data and clinical results through both companies’ digital platforms. The integration aims to provide a more continuous view of individual health by combining routine measurements with periodic laboratory assessments.Under the agreement, Function members can synchronize data from Withings devices directly into the Function app, including body com...
After The BioWare Shutdown, Mass Effect Spiritual Successor Exodus Gets A New Look
Timing is everything.
Told he was science fiction: Now the tissue he printed restored people's sight
A decade after founding Precise Bio, five patients at Rambam Health Care Campus have already received corneal implants produced by the company. And what about printing other organs?
National High Magnetic Field Laboratory will develop cutting-edge nuclear magnetic resonance facility with $18M in funding
The project supports National Science Foundation priorities in biotechnology, energy, advanced manufacturing and health The National High Magnetic Field
Mass Effect 5 trailer leaks following BioWare shutdown
A brief look at what “Mass Effect: Universe” could have been.
'Mass Effect Universe' Trailer Leaks A Day After BioWare Shutters
A short clip teases what is essentially Mass Effect 5
Omaha Science Café Explores the Wild World of Spiders Oct. 27
UNL biologist Eileen Hebets, PhD, presents a talk on spiders at the Oct. 27 Omaha Science Café at the Rathskeller Bier Haus. Open to ages 21 and older.
BioNexus KC celebrates ‘regional backbone’ connecting science, talent, tech and momentum
The scale of opportunities within Kansas City’s bio health industry would’ve been challenging to imagine even just five years ago, said Dennis Ridenour, touting a streak of groundbreakings, collaborations, game-changing announcements, and major investments — all rallying together the right people and institutions.
Lin to deliver APHA's Lowell Reed Lecture honoring contributions to public health statistics - UNC Gillings School of Global Public Health
Oct. 22, 2026 The American Public Health Association has selected Dr. Danyu Lin, Dennis Gillings Distinguished Professor of Biostatistics, as the 2026 Lowell Reed Lecturer, one of the organization’s highest honors for statistical innovation.
Video game developer BioWare shuts down, next ‘Mass Effect’ canceled amid broader layoffs at EA
Saudi Arabia’s sovereign wealth fund, with a firm run by Jared Kushner, bought EA in August.
Alumnus honors his father, a longtime Marquette professor, with $2 million gift to advance research in biological sciences
President Kimo Ah Yun announced today that a $2 million gift from alumnus Nanda Alapati will advance undergraduate and graduate research in biological sciences.
BioVivo Science secures organic certification for US facility and broccoli seed ingredient
The firm has secured organic certification for its Indiana botanical extraction facility and BrocoVio O broccoli seed ingredient, strengthening its US-made organic ingredient offering ahead of SupplySide Global
How Systems Biology Is Adopting an Engineering Framework
Everything from metabolic pathways optimized for efficiency to brain blood vessels designed as protective shock absorbers demonstrates multi-level planning.
Call for Abstracts — 2027 Petrie-Flom Center Annual Conference: Generative AI in Healthcare: Law & Regulation - Petrie-Flom Center
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is pleased to announce our 2027 Annual Conference, Generative AI in Healthcare: Law and Regulation. Generative AI –- artificial intelligence designed to produce output, such as text or images, that normally require human intelligence — has become a…
Influential Women Showcases Madison Tyler: Making Complex Biomedical Science Clear, Accurate, And Accessible
Founder of MAT Communications Brings Research Experience and Scientific Writing Expertise to Science Communications and Medical Affairs Salem, Connecticut –
Why we’re still so obsessed with Elizabeth Holmes
You Can See Everything, a documentary about the disgraced biotech company founder Elizabeth Holmes, has enjoyed a record-breaking opening in the US. It is a testament to how fascinated we remain by the convicted fraudster, but what is behind the enduring appeal? US technology editor Blake Montgomery tells Madeleine Finlay why Holmes continues to fascinate us, and reflects on whether the Theranos scandal has had a permanent impact on Silicon Valley
Hugging Face’s New AI Biology Model Lets You Chat With DNA
The new open-source model speaks the language of DNA and can help researchers understand the effects of any changes on gene activity and health.
Academic Scientists’ Career Confidence Fell Amidst US Policy Changes
A new NBER working paper surveying 916 biomedical PhD students and postdocs found academia-retention intentions fell 22 percentage points in six months.
Prime Video drops trailer for Muhammad Ali biographical series ‘The Greatest’
Prime Video has released the official trailer for “The Greatest,” an upcoming biographical drama chronicling the life and legacy of boxing legend Muhammad Ali. The series follows Ali from his early years as Cassius Clay in Louisville,
Manchester United should appoint Fabio Hurzeler if they replace Michel Carrick, says former Premier League winner Alan Shearer
Plus: Man Utd could trigger the 12-month extension clause in Lisandro Martinezs contract in order to recoup a fee for him; Man Utd fear Benjamin Sesko could be out until the new year; Vinicius Junior was serious about joining Arsenal this summer, but his heart made him stay at Real Madrid
China biotech RiboX reveals first data of circular RNA therapies in people
RiboX Therapeutics published first circular RNA clinical data in NEJM, showing RXRG001 improved saliva in xerostomia patients, ahead of Orna, Orbital, and Sail Biomedicines.
Rubio's India Trip Focuses on Business
The top U.S. diplomat’s three-day trip is focused largely on commercial interests.
BioWare closed by EA after 30 years of influential, genre-defining games
Development on the next Mass Effect game has been discontinued.
BioWare Becomes First Major Casualty Of Saudi Arabia's EA Takeover
When news came out that Saudi Arabia’s Public Investment Fund had taken a majority stake in Electronic Arts last September, it was clear to anyone familiar with Saudi Arabia, EA, private equity, or capitalism that the move would make an already terrible gaming company even worse. I wrote as much at the time, and though…
RIP BioWare: EA shuts down storied RPG studio after over three decades
Next Mass Effect project canceled as parent company lays off 400.
Electronic Arts Closing BioWare, Laying Off Hundreds
Around 400 people are expected to be laid off across Electronic Arts
EA Layoffs Cut 3%, BioWare Shutting Down, Star Wars: Battlefront 3 in Works
EA is restructuring its studios, laying off 3% of employees. BioWare is shutting down, while Respawn and DICE are teaming for 'Star Wars: Battlefront 3.'
Huck lecture series to feature bioengineering, environmental toxicology experts
The Huck Institutes of the Life Sciences will welcome two leading researchers to Penn State this fall as part of its Distinguished Lectures in Life Science series, with talks covering advances in regenerative medicine and the emerging science of nanoplastics exposure.
From PMS to Menopause: Two new clinical studies strengthen the science behind one saffron extract
PMS and menopause represent distinct stages of a woman’s life, with different hormonal patterns and symptoms. Yet both are characterised by significant hormonal fluctuations that can influence interconnected biological pathways involved in emotional well-being, sleep, stress response and overall quality of life
2026 Honored Alumni Lecture: Science and Faith are Friends, Not Foes
Cellular biologist Jeff Stogsdill returned to BYU as the 2026 Life Sciences Honored Alumni and gave a lecture sharing how faith and science don't compete; they complement each other.
Australia urged to put biodiversity at the heart of planning as global targets slip out of reach
The world is falling short of its biodiversity commitments because nature is still treated as an afterthought in decisions about housing, infrastructure, agriculture, energy, mining and conservation, ...
OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools
OpenAI will fold Orchestra's team and technology into Rosalind, its AI models and tools for life sciences researchers
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Too much RNA can starve cells of energy, scientists discover
Scientists have uncovered an unexpected danger lurking inside cells: too much RNA can damage the structures responsible for producing energy. A new study found that excess RNA, including the normally essential messenger RNA (mRNA), can directly disrupt mitochondria without relying on the immune system. The discovery could help explain how viral infections and certain aging-related diseases damage cells.
Cruz Foam had a promising idea. Why couldn’t it make its sustainable packaging business work?
Cruz Foam's biodegradable packing material made from shrimp shells and food waste attracted wide attention and big-name investors, but the Santa Cruz-based company has closed up shop after what one former exec says were struggles to solve the full range of problems its customers needed packaging to address.
This week in Santa Cruz County business: Cruz Foam ceases operations; West Coast Community Bank celebrates Nasdaq listing
Santa Cruz-based Cruz Foam, which developed a biodegradable packaging made from shrimp shells and other natural materials, has closed and sold off its intellectual property, Jessica M. Pasko reports in her weekly look at local business. Meanwhile, Santa Cruz-based West Coast Community Bancorp has moved its stock listing to the Nasdaq Stock Market, a milestone executives say is more than two decades in the making.
Marco Rubio and President Mirziyoyev Highlight U.S.–Uzbekistan Economic Cooperation at Business and Investment Council
To publish news and commentary - without fear or favor - in the finest tradition of independent journalism
Research report: Digital Science and Sunmedia partner to bring research impact reporting to Japan’s medical affairs teams
Sunmedia will use Dimensions and Altmetric data in customized reports intended to assess attention, sentiment and real-world connections for Japanese medical affairs teams.
UAB opens Shelby Biosciences Research Building to advance health
UAB has opened the Shelby Biosciences Research Building, an eight-story facility named after former U.S. Sen. Richard Shelby, aimed at supporting health research and creating new jobs.
How a photo of a person’s face could help predict whether they’ll survive cancer treatment
A simple selfie could hold surprising clues to your overall health and longevity, especially among people with cancer.
New Richland Lab Could Transform How Scientists Study Microbes and Boost Regional Jobs
The BriefGroundbreaking held Tuesday: PNNL officially began construction on the M2PC lab, a 30,800-square-foot facility funded by the U.S. Department of Energy's Office of Science that will study soil microbes to improve crop productivity and develop new biotechnology applications. The facility will be open to researchers from around the nation and the world.Research timelines could shrink dramatically: The facility's automation and AI capabilities could reduce experiments that currently take six months to just 72 hours, allowing scientists to explore more possibilities faster than ever before.New jobs coming to the Tri-Cities: The project is expected to create positions for automation engineers, AI experts, roboticists, technicians, and skilled craftspeople, with the facility opening in 2029.RICHLAND, Wash. — Pacific Northwest National Laboratory broke ground Tuesday on a first-of-its-kind facility that could accelerate scientific discoveries about the microscopic organisms living in soil—organisms that may hold the key to growing more food and developing new energy technologies.The Microbial Molecular Phenotyping Capability, or M2PC, represents a significant investment in automation and artificial intelligence to speed up research that traditionally takes years to complete. The 30,800-square-foot facility will house more than 100 connected automated instruments designed to study microbes at a pace and scale never before possible.Reshaping Agriculture's FutureThe M2PC facility will not put a new tool directly into a farmer's hands tomorrow morning, but it is actively reshaping the commercial pipeline to solve agriculture's biggest headache with biologicals: inconsistent field performance. For years, PNNL researchers have explored how microbes work and how they might help produce useful materials, advance energy technologies, and address challenges involving critical materials and minerals. But those experiments have been limited by what researchers could accomplish by hand."They can be used to provide nutrients to a plant so that the plant would grow more. So, like increasing your crop productivity, for example," said Douglas Mans, PNNL's Associate Laboratory Director for Integrated Discovery Sciences.PNNL's own research shows soil microbes can help plants access nutrients and withstand drought—benefits that could prove crucial as farmers face growing environmental pressures. The M2PC facility will allow scientists to identify and optimize useful microbes faster than ever before, accelerating the development of biological solutions that actually work consistently in the field.What Makes M2PC UniqueThe Microbial Molecular Phenotyping Capability differs from traditional research labs because it operates as a first-of-its-kind, AI-enabled autonomous laboratory designed to shrink experimental timelines from years down to months or weeks. The M2PC lab will connect more than 100 automated instruments to grow microbes, prepare samples, measure their behavior, and link observations to the molecular processes behind them. Artificial intelligence will help analyze results and guide the next experiments, allowing scientists to explore more questions faster.Deb Gracio, PNNL Director, emphasized the transformative potential during Tuesday's groundbreaking ceremony: "Research that has taken years will become possible in months and hopefully in weeks."That acceleration is already being demonstrated. PNNL's smaller automated lab, called the Anaerobic Microbial Phenotyping Platform or AMP2, completed three experimental cycles in just 72 hours—a process that normally would have taken about six months."That normally would have taken us about six months … and we were able to do that in 72 hours," Mans said.The AMP2 laboratory is not being closed or replaced. Instead, the current 1,800-square-foot laboratory serves as an active prototype and precursor for the much larger M2PC facility. AMP2 will continue operating as a separate lab designed to run anaerobic experiments—those conducted in the absence of oxygen—while M2PC will focus on aerobic research.Broader Applications Beyond AgricultureWhile improving crop productivity is one important application, the M2PC facility is designed to support research into multiple areas critical to national priorities. The lab will advance research into biofuels, manufacturing materials, and energy technologies. It will also help researchers understand how microbes respond to environmental changes and how to design biological systems for biotechnology applications.As a flagship component of the Department of Energy's Genesis Mission, M2PC represents a significant investment in using artificial intelligence and automation to accelerate U.S. scientific discovery. Dorothy Koch, Associate Director of the DOE Office of Science Biological and Environmental Research program, highlighted the facility's importance during the groundbreaking."M2PC will accelerate biological discovery and design," Koch said, noting that the facility is expected to conduct a minimum of 500 strain experiments per week, 100 microbiome experiments per week, and take a million measurements per month.Economic Opportunity for the RegionBeyond the scientific breakthroughs, the M2PC project represents significant economic opportunity for the Tri-Cities region. The facility will require hiring automation engineers, AI experts, technicians skilled in operating robotics, and specialized craftspeople to build and maintain the sophisticated equipment."We're anticipating that type of hiring," Mans said when asked about job creation.PNNL has already begun recruiting talent nationally and internationally for positions related to the smaller AMP2 lab, bringing automation engineers from cities like Boston and San Francisco to work in the region. The M2PC facility is expected to accelerate that trend."This capability won't really exist anywhere else in the world," Mans said, suggesting the facility could become a draw for scientific talent seeking to work on cutting-edge biotechnology research.Timeline and Next StepsThe M2PC facility is expected to open in 2029. Between now and then, construction crews will level and prepare the ground, while the building takes shape. Simultaneously, Ginkgo Bio Works, the automation contractor, will build the facility's automation components off-site so they can be installed as the building is completed.In the interim, PNNL researchers and the broader scientific community will begin planning the first experiments to be conducted in the facility, ensuring research is lined up and ready to begin as soon as the doors open.The groundbreaking ceremony included representatives from the Department of Energy, PNNL leadership, and elected officials at the federal, state, and local levels, underscoring the project's significance to the region and the nation's biotechnology future. News The U.S. Department of Energy Secretary tours Pacific Northwest National Laboratory Dan Hanson, Apple Valley News Now News Beyond DNA: Scientists Explore New Frontiers in Biology Research Dan Hanson, Apple Valley News Now News TRIDEC optimistic that Hanford, PNNL will see funding in national budget Robert Desaulniers News Big picture science: monitoring the Yakima River Basin News PNNL research could shape the future of fighting fentanyl COPYRIGHT 2026 BY APPLE VALLEY NEWS NOW. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.
Scientists Use Ancient Rains to Map the Possible Origin Life on Mars
Billions of years ago, rain may have helped shape where the chemistry of life could begin on Mars. A new study maps how formaldehyde, an important prebiotic molecule, may have reached the surface. This map could help guide future missions searching for signs of past life on Mars.
OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
/PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...
Scientists Say Honey Bee Colonies Are Superorganisms and We've Been Understanding Them All Wrong
A radical rethink of honey bee biology challenges how scientists understand swarming and even beekeeping.
Guardant Health to Highlight Advances in Liquid Biopsy for Cancer Monitoring at ESMO 2026
Guardant Health and partners will present 25 abstracts on liquid biopsy advances for cancer monitoring at ESMO 2026.
Understanding Intelligence Across Artificial and Biological Systems
Recently I started a new peer-reviewed journal at the crossroads of Artificial Intelligence and Cognition research. The journal, titled "AI and Brain", is published by Scilight Press, a young
Prenosis and Carle Health Mark Sepsis ImmunoScore® Clinical Deployment and First Patients Enrolled in OBSERVE-ARDS Clinical Study
/PRNewswire/ -- Prenosis®, a biology-based technology company delivering precision therapeutics, today announced three milestones in its ongoing relationship...
Life Science Connect Acquires BrevisRefero to Expand Biopharma Outsourcing Technology Capabilities
Life Science Connect (LSC) has acquired Toronto-based BrevisRefero Corporation, a biopharmaceutical consulting firm and developer of the RFP>Navigator® platform, expanding... Read More
Could AI Use a Simple Photo of Your Face to Reveal Clues About Your Health?
A new AI model can estimate biological age and predict cancer survival outcomes using a simple photo of a patient’s face, though more research is needed before doctors will be able to use it to help them decide on treatments.
‘These risks are real’: the threat of AI bioweapons
In his annual speech on threats to the nation, Sir Ken McCallum, the head of the UK’s intelligence service, MI5, warned that AI had the potential to ‘change the stakes’ on existing and even new bioweapons. To find out why, and how, Ian Sample speaks to Dr Tom Inglesby, director of the Johns Hopkins Center for Health Security and the Bloomberg School of Public Health. He explains what has governments so worried and what measures could be put in place to reduce the risks
Start-Up Claims to Treat a Patient With A.I.-Created Viruses
Certain viruses attack bacteria and can sometimes clear antibiotic-resistant infections. Researchers said they had tailored a virus to attack one patient’s illness.
Biotech firm Colossal set to return extinct bird’s egg to New Zealand
The biotech firm trying to bring extinct species back to life, Colossal Biosciences Inc., will return an egg from the flightless moa to its native New Zealand.
Scientists get funding to tackle 'biosecurity threat'
A University of Surrey team is helping develop a vaccine against a bacteria affecting poultry.
Uzbekistan's $12bn business drive gathers pace during Rubio visit
The package covers railways, critical minerals, finance and technology, with major US firms involved. Uzbek President Mirziyoyev outlined measures to attract investors, while business executives told Euronews that commercial activity is growing.
The art of science: MU students make art inspired by biology, anthropology departments
HUNTINGTON — Some artists would get mad if someone drove over their artwork, but that wasn’t the case in Pullman Square on Friday evening.
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
Pfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this marks the end of the road for the asset. The Big Pharma had been evaluating the therapy, dubbed PF-06835375, in a phase 2 study of 61 patients with primary immune thrombocytopenia (ITP) that kicked off in 2022, according to the federal trials register. However, Pfizer confirmed to Fierce on Monday that this study had been terminated “due to a business decision.” “The decision to terminate the trial was not based on any safety concerns,” a spokesperson pointed out. At time of publication, PF-06835375 remained listed on Pfizer’s website for both ITP and lupus. A phase 1 study in lupus wrapped up in 2022, according to the trials database. ITP is an autoimmune disorder characterized by a low platelet count. Novartis was at one point evaluating its B-cell-depleting antibody ianalumab—recently approved as Fabhalta to treat immunoglobulin A nephropathy—as a potential treatment ITP. But the therapy struggled to demonstrate a benefit in the clinic for this indication. When contacted by Fierce, Pfizer wouldn’t confirm whether all work on PF-06835375 has been halted, and whether the company has any other plans to explore C-X-C chemokine receptor type 5 (CXCR5) as a mechanism. CXCR5 is found in blood cancers such as diffuse large B-cell lymphoma and mantle cell lymphoma chemokine receptor. However, there is little expression in normal tissue, which has led some drug developers to explore its potential. Vincerx Pharma had at one point been planning to take an anti-CXCR5 ADC into the clinic to treat B-cell malignancies, but that ambition was scrapped due to cash constraints. Where Big Pharma is placing its bets is one of the hot topics being discussed at Fierce Biotech's high-impact event in London next month. Find out more information and register by clicking on the banner below: [ ](https://qtxasset.com/quartz/qcloud5/media/image/where_big_pharma_is_placing_its_bets.png?VersionId=B8JrRbJ.pFUSK1pJgjeWHLGm_18RdLAy)
Lil Jon recalls learning man who raised him isn’t his biological father
The rapper writes about the experience in his new memoir, “I Only Shout So You Can Hear Me.”
Your age may not tell the whole story about how healthy you are
Researchers developed a five-factor Lifestyle Index assessing physical activity, BMI, smoking, sleep quality, and sexual satisfaction in 312 Swiss adults aged 35 to 65 years. Higher scores were modestly associated with younger bio-functional age, suggesting a relationship between combined lifestyle patterns and functional health, although the findings cannot establish causation.
Magnolia Heights students visit Northwest Mississippi Community College for science field trip
Students from Magnolia Heights explored biology and chemistry through campus labs and hands-on experiments, according to Northwest Mississippi Community College.
Advancing Women's Health to Improve Outcomes in All Phases of Life
The Executive Order (“EO”) makes it federal policy to prioritize turning women’s health research into better clinical care at every life stage, and it directs HHS, through NIH, to set up a new Women’s Health Division within 90 days. In coordination with the NIH Office of Research on Women’s Health, the Division will focus on, among other things, understudied women’s health conditions, greater inclusion of women and girls in clinical trials and grant recipients’ adherence to NIH's policy on sex as a biological variable. The EO also creates a White House Women’s Health Task Force, co-chaired by the Secretary of HHS and the Assistant to the President and Chief of Staff and composed of officials from other departments and agencies.
AI facial health recognition tools help physicians assess age and survival risk to guide personalized treatment
Mass General Brigham researchers trained a new AI foundation model on more than 40 million facial images, and used it to develop AI tools to estimate biological age and directly predict survival risk in patients with cancer
What Does a Human Heart Need to Grow? Scientists Found the Answer in a Bioprinted Model
Heart problems that babies are born with, called congenital heart defects, often begin developing early in pregnancy. Approximately three weeks after fertilization, the human heart is still a simple, straight tube of cells and, over the course of about five weeks, this tiny structure must undergo a remarkable transformation to reshape itself into the complex organ that eventually pumps blood throughout the body.
Arpit Davé on Using Tech to Deliver Greater Impact for Patients
Learn how BioMarin’s Chief Digital and Information Officer envisions using technology to accelerate innovation for people with rare genetic conditions.
Scientists Create “Super Ice” That’s 10 Times Stronger and Rivals Concrete in Strength
A new form of reinforced ice could offer an unconventional building material for extreme polar environments, although questions about its long-term durability remain. Scientists have developed a new form of ice that approaches the compressive strength of conventional concrete while resisting the sudden fractures that make ordinary ice so brittle. Known as BioPykrete, the material
Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
Ganglberger and colleagues assessed a deep learning model’s ability to derive brain health scores from electroencephalography data.
Hackers Exploit Plex2Shell Flaws to Install Crypto Miners and Linux Proxy Backdoor
Attackers exploit four Plex Media Server flaws chained as Plex2Shell to deploy XMRig miners and reverse proxy software after PoC release.
NQPI welcomes Professor Michael Held, strengthening connections between molecular biology and nanoscale materials research
The Nanoscale and Quantum Phenomena Institute (NQPI) at Ohio University welcomes Professor Michael Held as its newest faculty member.
Does your gut health predict a vaccine fever?
New research suggests your gut microbiome may influence whether you develop a fever after receiving a vaccination.
How a Monk, an Emperor, and Cave Beetles Built the Science of Underground Life
In the mid-nineteenth century, the study of life in caves was not the work of laboratories or universities but of monks, aristocrats, merchants, and soldiers, all bound together by the ambitions of an empire. A new historical study published in
Verily Health to Integrate PacBio HiFi Sequencing With Data Platform
The multi-year collaboration will link PacBio sequencing workflows to Verily Pre to support biomedical research and AI model training.
Paul Harris elected to National Academy of Medicine
Paul Harris, PhD, Professor of Biomedical Informatics at Vanderbilt Health, has been elected to the National Academy of Medicine (NAM).
In memoriam: Frank M. Ahern, teaching professor emeritus of biobehavioral health
The College of Health and Human Development is saddened to share the news that Frank Ahern, teaching professor emeritus of biobehavioral health, passed away last month. Ahern came to Penn State in 1983 as a senior research associate in the Department of Health Policy and Administration and went on to co-found the Department of Biobehavioral Health in 1991.
Pierre Sage to remain Crystal Palace manager, but…
Despite being thrashed 5-0 by Brighton & Hove Albion at the weekend, Pierre Sage is nevertheless expected to be given more time to prove himself as Crystal Palace manager, according to reports in The ...
Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
/PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative...
Whitlam would push Australian PM Albanese to go ‘bigger and bolder,’ biographer says
Albanese read the biography in office, calling its author to discuss Whitlam’s political mistakes as he encountered them.
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq:...
‘Clean’ energy, local costs: Advocates challenge bioenergy’s climate claims
Companies market wood pellets and hog biogas as climate solutions. Critics say neighbors are exposed to health risks and life quality issues.
From Nanochemistry to Smart Roads: The Multi-Scale Science Transforming Sustainable Pavements
A new Frontiers in Materials editorial maps how functional additives, multi-scale analysis, and machine learning are turning road construction into a quantifiably sustainable, data-driven discipline.
New Tools and Fresh Thinking Are Reshaping the Science of Addiction
A new Frontiers Research Topic argues that biosensors, longitudinal phenotyping, and transdiagnostic biomarkers are transforming addiction from a static label into a dynamic, mechanism-based science.
Novichok Nerve Agents: What Science Actually Knows About the Deadliest Weapons
A new review finds that while Novichok agents potently inhibit acetylcholinesterase and modern forensics can verify exposure, many claimed properties of these weapons remain unvalidated by experiments on authenticated compounds.
Microalgae could make a common antibiotic more effective
Scientists have turned microalgae into an unlikely drug-delivery vehicle, using it to boost the effectiveness of a common antibiotic.
Gut Microbiome and Aging: How Gut Bacteria Influence Health and Longevity
The gut microbiome changes with age, with microbial diversity and function varying according to health status, diet, lifestyle, and medication use. These changes are associated with inflammation and age-related diseases, but evidence that microbiome-targeted interventions extend human lifespan remains limited.
Four Tiny Snail Species New to Science Found on Limestone Karsts of Laos
Biodiversity surveys on Laos limestone karsts have revealed eight Alycaeinae micro land snail species, four of which are new to science, highlighting the urgent need to protect these overlooked ecosystems.
Your age may not tell the whole story about your health, but your blood could
Researchers analyzed plasma metabolites from 18,476 individuals aged 1 to 96 years and developed two metabolomic aging measures to assess biological aging, chronic disease, and mortality risk. Accelerated metabolomic aging was associated with greater risks of chronic disease and death, while a separate mortality-linked measure provided additional information about health status and disease burden beyond conventional clinical assessments.
Marshmallow Root’s Chemistry Revealed: The Science Behind an Ancient Cough Remedy
A new review in Pharmacia compiles the chemical compounds and pharmacological effects of Althaea officinalis, the marshmallow plant long used for coughs, wounds, and inflammation.
Rubio heads to Central Asia as some wonder if he's keeping the most pressing matters at a distance
This tour is intended to promote U.S. economic and security ties with Central and South Asia. But it has only tangential links to the Trump administration’s current main foreign policy dilemmas in the Middle East and with the Russia-Ukraine war.